- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/02 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
Patent holdings for IPC class C07D 401/02
Total number of patents in this class: 631
10-year publication summary
|
34
|
40
|
44
|
34
|
29
|
28
|
31
|
38
|
30
|
31
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2190 |
15 |
| Boehringer Ingelheim International GmbH | 4644 |
13 |
| AstraZeneca AB | 2854 |
11 |
| Medshine Discovery Inc. | 598 |
11 |
| Merck Sharp & Dohme LLC | 3735 |
10 |
| Bristol-myers Squibb Company | 4833 |
9 |
| Janssen Pharmaceutica N.V. | 3351 |
7 |
| Abbvie Inc. | 1813 |
7 |
| Vertex Pharmaceuticals Incorporated | 1621 |
7 |
| RespiVert Ltd. | 79 |
7 |
| Sunshine Lake Pharma Co., Ltd. | 600 |
7 |
| Epizyme, Inc. | 374 |
6 |
| MyoKardia, Inc. | 121 |
6 |
| Xizang Haisco Pharmaceutical Co., Ltd. | 110 |
6 |
| The Regents of the University of California | 20245 |
5 |
| Alcon, Inc. | 5508 |
5 |
| Angion Biomedica Corp. | 60 |
5 |
| BeiGene, Ltd. | 364 |
5 |
| Nanoquantum Sciences, Inc. | 6 |
5 |
| Insilico Medicine IP Limited | 141 |
5 |
| Other owners | 479 |